What to Expect When Switching to a Second Antidepressant Medication Following an Ineffective Initial SSRI: A Report From the Randomized Clinical STAR*D Study.
CONCLUSIONS: Following nonefficacy with an initial SSRI, only about 20% remit and more than half achieve no meaningful benefit with a second-step switch to another monoaminergic antidepressant. A 12-week trial duration seems necessary to capture as many second-step switch responders as possible.
TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT00021528.
PMID: 32780949 [PubMed - in process]
Source: Journal of Clinical Psychiatry - Category: Psychiatry Tags: J Clin Psychiatry Source Type: research
More News: Bupropion | Celexa | Citalopram | Clinical Trials | Depression | Effexor | Psychiatry | Sertraline | Study | Wellbutrin | Zoloft